Thank you very much, Mr. Chair.
Thank you to our witnesses as well.
We heard in the previous panel about a need to focus our research and development. I think Mr. Lemieux just mentioned that in his question.
My question is for Dr. Turcotte. He's talking about the Sherbrooke cyclotron. We have a world-leading facility as well in British Columbia, the TRIUMF laboratory. We heard from some witnesses today about the need for an NRU replacement, and we've seen that there is a possibility. You talked about the commercialization in 2018 of Tc-99m medical isotopes being created in a non-nuclear facility such as yours.
Given that there is a scarcity of resources, where do you believe the government should be focusing its funding going forward? Is it in the new technologies? Do we need to have both? I don't expect you to be able to say whether the government can afford that, but I imagine it would be very expensive to maintain both at a world-leading capacity.
If you could talk about your perspective on that first, then I'll go to the panel that's here in Ottawa.